Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia

Predictive factors for poor prognosis febrile neutropenia

(2012) Shin Ahn et al.   CURRENT OPINION IN ONCOLOGY

Predictive factors of bacteraemia in low-risk patients with febrile neutropenia

(2011) Shin Ahn et al.   EMERGENCY MEDICINE JOURNAL

Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy

(2010) Young Eun Ha et al.   SUPPORTIVE CARE IN CANCER

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

(2010) Marianne Paesmans et al.   SUPPORTIVE CARE IN CANCER

Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network

(2010) Edwin Pun Hui et al.   SUPPORTIVE CARE IN CANCER

Bloodstream infections in cancer patients with febrile neutropenia

(2008) Ronald Feld   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS